Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Controlled Clinical Trials|December 4, 2003
Overview of the DIG trialJoseph F Collins, Debra Egan, Salim Yusuf, et al.
Clinical Transplantation|April 3, 2016
Hormone resuscitation therapy for brain-dead donors - is insulin beneficial or detrimental?Dimitri Novitzky, Zhibao Mi, Luis A Videla, et al.
Controlled Clinical Trials|December 4, 2003
Lessons learned from the DIG trialDebra Egan, Nancy Geller, Salim Yusuf, et al.
Controlled Clinical Trials|December 4, 2003
The role of the pharmacy coordinating center in the DIG trialCarol L Fye, William H Gagne, Dennis W Raisch, et al.
Journal of the American Pharmacists Association : Japha|February 26, 2005
Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependenceDennis W Raisch, Paul J Fudala, Andrew J Saxon, et al.
Therapeutic Drug Monitoring|March 13, 2012
Population pharmacokinetics of carbamazepine in elderly patientsBaralee Punyawudho, Eugene R Ramsay, Richard C Brundage, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 8, 2011
Predictors and impact of postoperative atrial fibrillation on patients' outcomes: a report from the Randomized On Versus Off Bypass trialG Hossein Almassi, Sharon A Pecsi, Joseph F Collins, et al.
Journal of Cardiac Failure|June 10, 2006
What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trialEric L Eisenstein, Salim Yusuf, Vishal Bindal, et al.
Pageof 8